CentraState Medical Center

IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class

Retrieved on: 
Monday, January 29, 2024
Surgical oncology, Neoplasm, CentraState Medical Center, Breast imaging, SIO, DRS, Interventional radiology, Society, Breast cancer, Freezing, Oncology, Principal investigator, Education, ICE3, Radiation, Interventional oncology, Master Class, Physician, Medical imaging

This year's SIO meeting featured an educational event, Breast Cryoablation Master Class , the first of its kind by a radiology society.

Key Points: 
  • This year's SIO meeting featured an educational event, Breast Cryoablation Master Class , the first of its kind by a radiology society.
  • Interventional oncologists attending the half-day course learned from multidisciplinary experts in breast imaging, breast surgery, interventional radiology, surgical oncology, medical oncology, and radiation oncology.
  • A literature review of notable studies for breast cryoablation was presented, primarily including interim data from IceCure's ICE3 breast cancer cryoablation study, which demonstrated a 96.91% recurrence free rate.
  • Dr. Tomkovich commented, "The Master Class, which was filled to capacity, included interventional oncologists and breast radiologists seeking education to build a successful breast cryoablation program.

IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India

Retrieved on: 
Monday, October 30, 2023
Neoplasm, Novomer, CentraState Medical Center, Cryoablation, Business development, Conference, Quality of life, Interventional radiology, Freezing, Interim, ICE3, Hospital, Breast cancer, Woman, Safety, Patient, Pharmaceutical industry, Medical imaging

ProSense® was featured at Novomed's booth where doctors had the opportunity to get hands-on experience with the cryoablation system.

Key Points: 
  • ProSense® was featured at Novomed's booth where doctors had the opportunity to get hands-on experience with the cryoablation system.
  • ProSense® was installed and inaugurated at Kovai Medical Center and Hospital in May 2023 and in June 2023 the first breast cancer cryoablation procedure in India was successfully conducted.
  • Interim results, which were previously published, show a 96.91% recurrence free rate, 100% safety, and 100% doctor and patient satisfaction with cosmetic results.
  • "In conjunction with Novomed, we are eager to have ProSense® rolled out to more hospitals in India.

Wildflower Health, Healthcare Transformation Consortium (HTC) Announce Groundbreaking Partnership to Launch Statewide Value-Based Maternity Care Model in New Jersey

Retrieved on: 
Thursday, February 2, 2023
HTC, Organization, Caregiver, Woman, Health, Physician, Hospital, Atlantic Health System, Periodic function, Patient, Leading, CentraState Medical Center, Holy Name Medical Center, Mortality, Virtua Health, Health care, Pregnancy, Partnership, SAN, Nursing, The Valley Hospital, Typology of business strategies, MD, Dietary supplement

NEWARK, N.J. and SAN FRANCISCO, Feb. 2, 2023 /PRNewswire-PRWeb/ -- Wildflower Health, a leading women's health solutions company, and Healthcare Transformation Consortium (HTC), a collaborative of independent health systems in New Jersey, today announced a groundbreaking partnership to launch a statewide value-based maternity care initiative that will transform the delivery and financing of maternity care. Initially, the value-based model will be delivered via a phased rollout to team members and dependents within HTC member health systems. Ultimately, Wildflower and HTC see opportunities to expand this approach to include other payers and self-insured employers.

Key Points: 
  • This platform includes educational content and tools for patients, and critical data for providers that can be accessed at point of care.
  • Additionally, clinicians will be able to leverage Health Advocates and Coaches from Wildflower to extend the impact of their internal teams.
  • This collaboration is one of the first regional networks of OB-GYN practices and hospitals aligning to transform care and transition toward value-based maternity care.
  • The Wildflower and HTC partnership officially launched January 1, 2023 with the value-based model being rolled out in phases within HTC member health systems.

IceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.

Retrieved on: 
Thursday, January 26, 2023
Interventional radiology, Medical imaging, Diagnosis, CentraState Medical Center, Associate, ICE3, Breast, TASE, Interventional oncology, Flexner Report, Woman, Breast cancer, Patient, Interventions, Freezing, Alpert Medical School, Neoplasm, Assistant

(NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing, today announced its participation in the Society of Interventional Oncology's Annual Scientific Meeting (" SIO2023 ") in Washington, D.C. on January 19 - 23, 2023.

Key Points: 
  • (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense® System that destroys tumors by freezing, today announced its participation in the Society of Interventional Oncology's Annual Scientific Meeting (" SIO2023 ") in Washington, D.C. on January 19 - 23, 2023.
  • ProSense was demonstrated throughout the duration of the conference at IceCure's booth.
  • Separately, in a breast session organized by SIO2023, ProSense was featured in a panel discussion on January 21st led by Dr. Kenneth Tomkovich and included Dr. Robert Ward, both ProSense users.
  • Commenting on the growing interest in ProSense, Dr. Tomkovich stated, "we are seeing increasing interest from interventional radiologists and interventional oncologists, many of whom are practitioners who previously were not treating breast cancer patients.

IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual Meeting

Retrieved on: 
Wednesday, November 30, 2022
CMS, Interventional radiology, Kidney, Food, Poster, RSNA, Centers for Medicare & Medicaid Services, Update, Patient, Regulation of tobacco by the U.S. Food and Drug Administration, Annual report, FDA, Radiological Society of North America, Annual general meeting, Classification, De novo, MD, Breast cancer, Interim, Neoplasm, Medicare, Diagnosis, CentraState Medical Center, Genta (company), LINK, Risk, TASE, ICE3, Securities & Exchange Commission of Pakistan, Clinical trial, CE marking, Breast, Freezing, Medical imaging

That Is The Question: Cryoablation For The Treatment Of Breast Cancer"

Key Points: 
  • That Is The Question: Cryoablation For The Treatment Of Breast Cancer"
    CAESAREA, Israel, Nov. 30, 2022 /PRNewswire/ -- IceCure Medical Ltd .
  • (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense System that destroys tumors by freezing, today announced that ProSense is featured in a poster presentation titled "To Freeze Or Not To Freeze?
  • That Is The Question: Cryoablation For The Treatment Of Breast Cancer" at RSNA 2022 , the Radiological Society of North America's ("RSNA") 108th Scientific Assembly and Annual Meeting which takes place from November 27th to December 1st, 2022 in Chicago.
  • RSNA is the largest radiology society in the world with over 48,000 members in the United States, representing 31 radiologic sub-specialties sharing state-of-the-art radiological innovations.

"Fitness & Wellness Professional Services to Select the Link+ Platform by LiveCare to Develop a Virtual Primary Care Program"

Retrieved on: 
Wednesday, November 2, 2022
Software as a service, Health, Partnership, Exercise, Organization, Wellness, Duke Diet and Fitness Center, Risk, RWJBarnabas Health, View, WPS, Patient, Hackensack Meridian Health, Multimedia, CentraState Medical Center, Movement, Health insurance, Medicine

Fitness & Wellness Professional Services (F&WPS) has an established network of 11 medically based fitness centers across New York, New Jersey and Pennsylvania.

Key Points: 
  • Fitness & Wellness Professional Services (F&WPS) has an established network of 11 medically based fitness centers across New York, New Jersey and Pennsylvania.
  • "Enhancing the connection between primary care clinics and communities they serve is what we're about" CEO Peri Avitan.
  • F&WPS is a management service organization that promotes fitness and wellness products and services for hospital partnered and/or owned medically based fitness centers.
  • LiveCare's mission is to create a more efficient primary care operating system by disrupting the status quo of today's primary care platforms.

IceCure Medical to Report H1 2022 Results and Conduct Conference Call on August 15, 2022

Retrieved on: 
Tuesday, August 9, 2022
Regulation of tobacco by the U.S. Food and Drug Administration, Update, RSNA, Breast, Technology, Private Securities Litigation Reform Act, Freezing, Respiratory Medicine, SEC, Clinical trial, CE marking, Diagnosis, Annual report, Neoplasm, American Journal, Interventional radiology, Company, Breast cancer, Risk, NASDAQ, Kidney, AME Publishing Company, CentraState Medical Center, EDT, TASE, Interventions, ICE3, Food, Medical imaging, Radiology

The conference call will be hosted by IceCure management who will be joined by Dr. Kenneth Tomkovich, Co-Primary investigator for IceCure's ICE3 clinical trial on cryoablation of small, low-risk breast cancer.

Key Points: 
  • The conference call will be hosted by IceCure management who will be joined by Dr. Kenneth Tomkovich, Co-Primary investigator for IceCure's ICE3 clinical trial on cryoablation of small, low-risk breast cancer.
  • Dr. Tomkovich is a Diagnostic and Interventional Radiologist with Princeton Radiology and Director of Breast Imaging and Interventions at CentraState Medical Center, New Jersey.
  • A prolific researcher, Dr. Tomkovich has authored or co-authored articles in several medical journals including Respiratory Medicine, Academic Radiology, Emergency Radiology, and the American Journal of Radiology.
  • Dr. Tomkovich presented interim data from the ICE3 clinical trial at the Radiologists Society of North America (RSNA) in 2021.

Atlantic Health System Chooses Aidoc for Medical AI Imaging Solution

Retrieved on: 
Tuesday, May 3, 2022
Newton, Radiology, U.S. News & World Report, Brain, Morristown Medical Center, CentraState Medical Center, Atlantic Health System, Medicine, Radiation, Physician, Doctor Foster, Triage, Patient, Partnership, CT, Diagnosis, Overlook Medical Center, Hospital, Workforce, Health, Garden State, News, Thrombus, Solution, CEO, Length of stay, AI, Bone fracture, Intelligence, Medical imaging, Medical device, Aidoc

NEW YORK, May 3, 2022 /PRNewswire/ -- Aidoc, the leading provider of healthcare AI solutions, today announced an agreement with Atlantic Health System, one of New Jersey's leading hospital networks. Atlantic Health rolled out Aidoc's AI solution to several hospitals within its vast network, which serves more than half of the Garden State's nine million residents. 

Key Points: 
  • NEW YORK, May 3, 2022 /PRNewswire/ -- Aidoc , the leading provider of healthcare AI solutions, today announced an agreement with Atlantic Health System, one of New Jersey's leading hospital networks.
  • Atlantic Health rolled out Aidoc's AI solution to several hospitals within its vast network, which serves more than half of the Garden State's nine million residents.
  • "We are honored to get the vote of confidence from Atlantic Health System," said Elad Walach, co-founder and CEO of Aidoc.
  • Atlantic Health System is at the forefront of medicine, setting standards for quality health care in New Jersey, Pennsylvania and the New York metropolitan area.

RECOVERY CENTERS OF AMERICA NAMED TIER 1 PROVIDER OF SUBSTANCE USE DISORDER TREATMENT FOR HEALTHCARE TRANSFORMATION CONSORTIUM TEAM MEMBERS

Retrieved on: 
Monday, February 7, 2022
GOP, Mirror Lake Recovery Center, Friends, Marlton, Front line, RCA, Virtua, Chair, Face, Transport, Anxiety, Saint Peter's Healthcare System, Joint, SUD, Program, IOP, Hospital, Patient, CentraState Medical Center, Atlantic Health System, Case management, Center, Shared services, Population, MAT, HTC, CEO, Addiction, Health, PHP, Nursing, Joint Commission, National Association, Partnership, Lighthouse, COVID-19, Health insurance, Medicine, Freehold, Raritan Bay

SOUTH AMBOY, N.J., Feb. 7, 2022 /PRNewswire/ -- Through a new partnership, team members at six New Jersey health systems can now access drug and alcohol addiction treatment at Recovery Centers of America (RCA) inpatient and outpatient facilities nationwide at significantly reduced out-of-pocket cost.  

Key Points: 
  • Recovery Centers of America at Westminster in Massachusetts recently launched Frontline , a confidential addiction recovery program for medical and behavioral health professionals.
  • Recovery Centers of America is accredited by the Joint Commission, CARF/ASAM and the National Association of Addiction Treatment Providers.
  • Members of the consortium include Atlantic Health System, CentraState Healthcare System, Holy Name, Hunterdon Healthcare, Virtua Health and Saint Peter's Healthcare System.
  • Recovery Centers of America is dedicated to helping patients achieve a life of recovery through evidence-based alcohol and drug addiction treatment.

PROCURE MARKS 6,000TH PATIENT TO COMPLETE TREATMENT

Retrieved on: 
Tuesday, January 18, 2022
Proton, Lung, Patient, Prostate, Proton therapy, Prostate cancer, Freedom, Physician, CentraState Medical Center, Procurement, Radiation, Cancer, Sarcoma, Northwell Health, Memorial Sloan Kettering Cancer Center, Extrapyramidal system, Head, Neck, New York University Grossman School of Medicine, Breast, Brain, Medical imaging, Montefiore

SOMERSET, N.J., Jan. 18, 2022 /PRNewswire/ -- ProCure Proton Therapy Center surpassed a major milestone Monday when Edmund Laska, 71, of Staten Island, NY, became its 6,000th patient to complete treatment since the center opened 10 years ago.

Key Points: 
  • SOMERSET, N.J., Jan. 18, 2022 /PRNewswire/ -- ProCure Proton Therapy Center surpassed a major milestone Monday when Edmund Laska, 71, of Staten Island, NY, became its 6,000th patient to complete treatment since the center opened 10 years ago.
  • "We were truly honored to play a part in Mr. Laska's cancer journey," said Dr. Brian Chon, ProCure Medical Director.
  • Treating 6,000 patients is a testament to the great team we have at ProCure and the effectiveness of proton therapy."
  • ProCure, located in Somerset, NJ, became the tri-state region's first proton therapy facility in 2012.